Colgate-Palmolive (NYSE:CL) Announces Earnings Results, Beats Estimates By $0.05 EPS

Colgate-Palmolive (NYSE:CL) issued its quarterly earnings data on Friday. The company reported $0.74 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.69 by $0.05, MarketWatch Earnings reports. Colgate-Palmolive had a net margin of 15.86% and a return on equity of 942.99%. The firm had revenue of $3.90 billion during the quarter, compared to the consensus estimate of $3.78 billion. During the same period last year, the business posted $0.72 earnings per share. The business’s revenue for the quarter was up .8% compared to the same quarter last year.

Shares of Colgate-Palmolive stock opened at $77.20 on Friday. The business has a 50-day simple moving average of $73.69 and a 200-day simple moving average of $71.47. The company has a debt-to-equity ratio of 21.51, a quick ratio of 0.66 and a current ratio of 0.96. The company has a market cap of $66.12 billion, a PE ratio of 26.35, a P/E/G ratio of 4.78 and a beta of 0.60. Colgate-Palmolive has a one year low of $58.49 and a one year high of $77.46.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be issued a $0.44 dividend. The ex-dividend date of this dividend is Friday, July 17th. This represents a $1.76 annualized dividend and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 62.19%.

In other news, Director Michael B. Polk sold 3,115 shares of the company’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $68.08, for a total transaction of $212,069.20. Following the completion of the sale, the director now owns 20,622 shares in the company, valued at $1,403,945.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.78% of the stock is currently owned by corporate insiders.

Several analysts recently weighed in on the stock. Stifel Nicolaus boosted their price objective on shares of Colgate-Palmolive from $72.00 to $75.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. SunTrust Banks upped their price objective on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the company a “buy” rating in a report on Friday, May 15th. Deutsche Bank upped their target price on shares of Colgate-Palmolive from $73.00 to $75.00 and gave the stock a “hold” rating in a report on Monday, July 27th. Credit Suisse Group reaffirmed a “sell” rating and issued a $67.00 price objective on shares of Colgate-Palmolive in a research report on Monday, May 4th. Finally, TheStreet downgraded shares of Colgate-Palmolive from a “b” rating to a “c+” rating in a report on Friday, May 1st. Three research analysts have rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $74.92.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Read More: Conference Calls

Earnings History for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with's FREE daily email newsletter.